13G Filing: Birchview Capital and Soleno Therapeutics Inc (SLNO)

Page 4 of 4

Page 4 of 4 – SEC Filing

CUSIP NO. 834203200 Page 4 of 4 Pages
Item 5. Ownership of Five Percent or Less of a Class:
This Item 5 is not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
This Item 6 is not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
This Item 7 is not applicable.
Item 8. Identification and Classification of Members of the Group:
This Item 8 is not applicable.
Item 9. Notice of Dissolution of Group:
This Item 9 is not applicable.
Item 10. Certification:

 

By signing below the Reporting Person certifies that, to the best of such person’s knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.

 

SIGNATURES

 

After reasonable inquiry
and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true,
complete and correct.

Date: December 26, 2017 Birchview Capital, LP
By: /s/ Richard McCormick
Richard McCormick
Chief Financial Officer

Follow Soleno Therapeutics Inc (NASDAQ:SLNO)

Page 4 of 4